Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Stock Short Interest Drops 36.9%

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the recipient of a significant drop in short interest during the month of September. As of September 15th, there was short interest totaling 4,130 shares, a drop of 36.9% from the August 31st total of 6,541 shares. Currently, 0.3% of the shares of the stock are short sold. Based on an average daily trading volume, of 5,757 shares, the short-interest ratio is presently 0.7 days.

Fidelity Disruptive Medicine ETF Price Performance

Shares of FMED stock traded down $0.16 during mid-day trading on Thursday, hitting $32.23. The company had a trading volume of 148 shares, compared to its average volume of 10,436. The stock’s 50 day moving average price is $30.91 and its 200-day moving average price is $27.62. Fidelity Disruptive Medicine ETF has a 52-week low of $23.48 and a 52-week high of $32.89. The company has a market capitalization of $51.57 million, a P/E ratio of 41.33 and a beta of 0.77.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Fidelity Disruptive Medicine ETF stock. Citadel Advisors LLC bought a new position in Fidelity Disruptive Medicine ETF (NASDAQ:FMED) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 9,896 shares of the company’s stock, valued at approximately $282,000. Citadel Advisors LLC owned about 0.62% of Fidelity Disruptive Medicine ETF at the end of the most recent quarter.

About Fidelity Disruptive Medicine ETF

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.